Lista de obras -

A flow cytometry based assay that simultaneously measures cytotoxicity and monocyte mediated antibody dependent effector activity

scientific article published on 24 August 2018

Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge

artículo científico publicado en 2020

Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors

artículo científico publicado en 2021

Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection

artículo científico publicado en 2016

Biomimetic Placenta-Fetus Model Demonstrating Maternal-Fetal Transmission and Fetal Neural Toxicity of Zika Virus

article

Clinical impact of vitamin D treatment in cystic fibrosis: a pilot randomized, controlled trial.

artículo científico publicado en 2016

Colony-stimulating factor-1- and interleukin-34-derived macrophages differ in their susceptibility to Mycobacterium marinum

artículo científico publicado en 2019

Dicer-2 Regulates Resistance and Maintains Homeostasis against Zika Virus Infection in

scientific article published on 10 October 2018

Dynamic MAIT cell response with progressively enhanced innateness during acute HIV-1 infection

scientific article published on 14 January 2020

Dysregulated CD1 profile in myeloid dendritic cells in CVID is normalized by IVIg treatment.

artículo científico publicado en 2013

Exosomes from breast milk inhibit HIV-1 infection of dendritic cells and subsequent viral transfer to CD4+ T cells.

artículo científico publicado en 2014

Human interleukin-34-derived macrophages have increased resistance to HIV-1 infection

scientific article published on 19 September 2018

IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis

artículo científico publicado en 2017

IL13Rα2 expression identifies tissue-resident IL-22 producing PLZF+ innate T cells in the human liver.

artículo científico publicado en 2018

IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID.

artículo científico publicado en 2013

Inhibition of B cell-mediated antigen presentation by intravenous immunoglobulins (IVIg)

scientific article published on 06 February 2010

Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion

artículo científico publicado en 2016

Invariant natural killer T cells in patients with common variable immunodeficiency.

artículo científico publicado en 2014

Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion

artículo científico publicado en 2016

Latent Mycobacterium tuberculosis Infection Is Associated With a Higher Frequency of Mucosal-Associated Invariant T and Invariant Natural Killer T Cells.

artículo científico publicado en 2018

Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV disease.

artículo científico publicado en 2018

Longitudinal Analysis of Peripheral and Colonic CD161<sup>+</sup> CD4<sup>+</sup> T Cell Dysfunction in Acute HIV-1 Infection and Effects of Early Treatment Initiation

artículo científico publicado en 2020

Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations

artículo científico publicado en 2021

MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications

artículo científico publicado en 2017

MicroRNAs 145 and 148a Are Upregulated During Congenital Zika Virus Infection

artículo científico publicado en 2019

Persistent Immune Activation in CVID and the Role of IVIg in Its Suppression.

artículo científico

RV144 HIV-1 vaccination impacts post-infection antibody responses

artículo científico publicado en 2020

Role of translocated bacterial flagellin in monocyte activation among individuals with chronic HIV-1 infection.

artículo científico publicado en 2015

Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2019

Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption

artículo científico publicado en 2020

Severely Impaired Control of Bacterial Infections in a Patient With Cystic Fibrosis Defective in Mucosal-Associated Invariant T Cells.

artículo científico publicado en 2018

T-cell Responses in Individuals Infected with Zika Virus and in Those Vaccinated Against Dengue Virus.

artículo científico

Vitamin D treatment modulates immune activation in cystic fibrosis.

artículo científico publicado en 2017

Lista de obras de

A flow cytometry based assay that simultaneously measures cytotoxicity and monocyte mediated antibody dependent effector activity

Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge

Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors

Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection

Biomimetic Placenta-Fetus Model Demonstrating Maternal-Fetal Transmission and Fetal Neural Toxicity of Zika Virus

Clinical impact of vitamin D treatment in cystic fibrosis: a pilot randomized, controlled trial.

Colony-stimulating factor-1- and interleukin-34-derived macrophages differ in their susceptibility to Mycobacterium marinum

Dicer-2 Regulates Resistance and Maintains Homeostasis against Zika Virus Infection in

Dynamic MAIT cell response with progressively enhanced innateness during acute HIV-1 infection

Dysregulated CD1 profile in myeloid dendritic cells in CVID is normalized by IVIg treatment.

Exosomes from breast milk inhibit HIV-1 infection of dendritic cells and subsequent viral transfer to CD4+ T cells.

Human interleukin-34-derived macrophages have increased resistance to HIV-1 infection

IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis

IL13Rα2 expression identifies tissue-resident IL-22 producing PLZF+ innate T cells in the human liver.

IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID.

Inhibition of B cell-mediated antigen presentation by intravenous immunoglobulins (IVIg)

Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion

Invariant natural killer T cells in patients with common variable immunodeficiency.

Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion

Latent Mycobacterium tuberculosis Infection Is Associated With a Higher Frequency of Mucosal-Associated Invariant T and Invariant Natural Killer T Cells.

Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV disease.

Longitudinal Analysis of Peripheral and Colonic CD161<sup>+</sup> CD4<sup>+</sup> T Cell Dysfunction in Acute HIV-1 Infection and Effects of Early Treatment Initiation

Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations

MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications

MicroRNAs 145 and 148a Are Upregulated During Congenital Zika Virus Infection

Persistent Immune Activation in CVID and the Role of IVIg in Its Suppression.

RV144 HIV-1 vaccination impacts post-infection antibody responses

Role of translocated bacterial flagellin in monocyte activation among individuals with chronic HIV-1 infection.

Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial

Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption

Severely Impaired Control of Bacterial Infections in a Patient With Cystic Fibrosis Defective in Mucosal-Associated Invariant T Cells.

T-cell Responses in Individuals Infected with Zika Virus and in Those Vaccinated Against Dengue Virus.

Vitamin D treatment modulates immune activation in cystic fibrosis.